Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Xiangtai Fishery is a vertically integrated aquaculture and marine biotechnology company headquartered in Hainan, China. Founded in 2004, the company oversees a comprehensive supply chain that includes fish breeding, ecological farming, and advanced aquatic processing. Beyond its position as a major seafood producer, Xiangtai has expanded into the life sciences sector through its marine biotechnology division, which specializes in the extraction of bioactive peptides from fish scales and skins. A significant milestone in this expansion is its joint venture with PB Leiner (part of the Tessenderlo Group), known as PB Leiner (Hainan) Biotechnology, which manufactures and commercializes premium fish collagen peptides under the SOLUGEL brand. These products are targeted at the global nutraceutical and cosmeceutical markets for applications in skin rejuvenation, joint health, and functional nutrition.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Xiangtai Fishery.